October 14th, 2026Coroner Reports Pennsylvania's Sixth Measles-Associated DeathThe Franklin County death is under state review as Pennsylvania's measles outbreak passed 1100 cases and 219 hospitalizations.Read more
October 14th, 2026Dyshidrotic Eczema Less Tied to Occupation Than Other Hand EczemaAmong 4378 Spanish registry patients, dyshidrotic eczema was less tied to occupation than other hand eczema.Read more
October 14th, 2026Non-CF Bronchiectasis Linked to High Medicare Use and SpendingNew non-CF bronchiectasis in Medicare is tied to high health care use and $8998 PPPM FFS spending; prevalence is highest in older women.Read more
October 14th, 2026Understanding the Potential Risks of Prescription Drug Affordability Boards and Upper Payment LimitsNPC researchers examined questions about how these policies could affect patients, pharmacies, and providers.Read more
October 14th, 2026Iberdomide Regimen Cuts RRMM Progression Risk by 51%, Trial FindsThese phase 3 EXCALIBER-RRMM findings build on earlier MRD-negative complete response results supporting FDA approval of the iberdomide-based regimen.Read more
October 14th, 2026Admilparant Phase 3 ALOFT-IPF Trial Meets Primary End Point in IPFAdmilparant 60 mg met the ALOFT-IPF primary end point, significantly improving FVC change vs placebo at 52 weeks in idiopathic pulmonary fibrosis.Read more
October 14th, 2026Postpartum Navigation Misses Primary Goal but Boosts Primary Care VisitsPostpartum navigation missed its primary goal but raised postpartum visits and primary care use among Medicaid-insured patients.Read more
October 14th, 2026Large French Cohort Finds Low Overall Infection Risk With Psoriasis BiologicsA 39,669-patient French cohort found ustekinumab and IL-23 inhibitors carry the lowest infection risk among biologics.Read more